In Swedish

Board

Anne-Charlotte Aronsson, Board MemberPh.D. in biochemistry. Business developer and marketer in the field of clinical diagnostics. Nowadays engaged as corporate board member and business coach.
Staffan Eriksson, Board MemberM.D., Ph.D., Professor Emeritus at SLU, Uppsala, Sweden. Director R&D, board member and consultant at AroCell.
Thomas Lund, Chairman of the BoardSeasoned entrepreneur and advisor
Magnus Aronsson, Deputy Board MemberM.Sc. at KTH Royal Institute of Technology, Stockholm, Sweden. International Product Manager at Roche Diagnostics, Switzerland
Jonas Eriksson, Deputy Board MemberM.Sc. in Business and Economics at Stockholm University, Sweden. In charge of business development at the Swedish branch of Adven – a company that supplies energy solutions.

Alertix Canine

Assay for early detection, monitoring and screening of tumor diseases in dogs. The assay is available to veterinary clinics and laboratories in Sweden and Scandinavia.
Read more about Alertix Canine

Alertix Feline

Assay for early detection, monitoring and screening of tumor diseases in cats. The assay is under development.
Read more about Alertix Feline
Under development

Alertix Equine

Assay for early detection, monitoring and screening of tumor diseases in horses. The assay is under development.
Under development
Read more about Alertix Equine

About cancer in companion animals

Did you know that our companion animals are afflicted by cancer as often as humans? Dogs and cats share not only our living environment but also our lifestyle. Because of this they are exposed to the same risk factors for cancer. Veterinary care is getting better and better at treating cancer in companion animals. But the crucial factor of success is that the disease is detected in time.

Read more about cancer in companion animals